Diabeto is a non-intrusive, Bluetooth-powered hardware device which wirelessly transmits glucose readings from a Glucometer into a smartphone. These readings can then be analysed with the help of a smartphone application for better manageability of diabetes.
Expert Collections containing Diabeto
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Diabeto is included in 1 Expert Collection, including Digital Health.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Latest Diabeto News
Mar 31, 2022
The foundation supporting technological entrepreneurship in the canton of Geneva, Fongit announces the first three beneficiaries of the Fongit Innovation Fund (FIF) for 2022. Diabeto received a grant of CHF 50,000. ORamaVR and Impaakt each received seed funding of CHF 100,000 in the form of convertible loans.
Diabeto Frequently Asked Questions (FAQ)
When was Diabeto founded?
Diabeto was founded in 2012.
Where is Diabeto's headquarters?
Diabeto's headquarters is located at 200 Centennial Avenue, Piscataway.
What is Diabeto's latest funding round?
Diabeto's latest funding round is Acquired.
Who are the investors of Diabeto?
Investors of Diabeto include Livongo and HAX.